ETFS Holding Biogen Idec Inc

 
ETF Quotes for ETFS Holding Biogen Idec Inc top ^
  • Holdings: Celgene Corp , Amgen Inc , Regeneron Pharmaceuticals Inc , Biogen Idec Inc , Gilead Sciences Inc ,
  • Morningstar Rating: 5 Stars
Sign-up for ibb investment picks
  • Holdings: TripAdvisor Inc , Alexion Pharmaceuticals Inc , United Rentals Inc , Biogen Idec Inc , Micron Technology Inc ,
  • Morningstar Rating: 4 Stars
Sign-up for sphb investment picks
  • Holdings: Djus Short Sml Size T , Djus Long Sml Size T , Hawaiian Electric Industries Inc , Office Depot Inc , Biogen Idec Inc ,
  • Morningstar Rating: 2 Stars
Sign-up for siz investment picks
  • Holdings: Gilead Sciences Inc , Amgen Inc , Celgene Corp , Biogen Idec Inc , Alexion Pharmaceuticals Inc ,
Sign-up for bbh investment picks
  • Holdings: Biogen Idec Inc , Gilead Sciences Inc , Visa Inc Class A , Bristol-Myers Squibb Company , Home Depot Inc ,
  • Morningstar Rating: 4 Stars
Sign-up for pwb investment picks
  • Holdings: Biogen Idec Inc , Gilead Sciences Inc , Biomarin Pharmaceutical Inc , Regeneron Pharmaceuticals Inc , Amgen Inc ,
  • Morningstar Rating: 4 Stars
Sign-up for pbe investment picks

 
Stock Quotes for Biogen Idec Inc top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Growth
  • Stock Type: Aggressive Growth
  • Morningstar Rating: 3 Stars
Sign-up for biib investment picks

 
News Articles for Biogen Idec Inc top ^
2014/10/8
Second paragraph, first sentence of release dated September 25, 2014 should read: Following the release of the financials, the Company will host a live webcast where Biogen Idec management will discuss the financial results, at 8:30 am ET.
Sign-up for CORRECTING and REPLACING Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 investment picks
Biogen Idec (NASDAQ:BIIB) has been named the biotechnology industry leader on the Dow Jones Sustainability World Index (DJSI World). The company also was named to the Dow Jones Sustainability Index (DJSI) North America for the fifth consecutive year, one of only two biotech companies included.
Sign-up for Biogen Idec Named Global Biotechnology Industry Leader on Dow Jones Sustainability World Index investment picks
Biogen Idec (NASDAQ:BIIB) today announced that Olivier Danos, Ph.D., has joined the company as senior vice president, Gene Therapy.
Sign-up for Olivier Danos Joins Biogen Idec as Senior Vice President, Gene Therapy investment picks
2014/10/15
Living with a chronic condition like multiple sclerosis (MS) can be overwhelming for individuals and caregivers who have to balance the challenges of everyday life and work while juggling regular doctors’ visits and medications.
Sign-up for Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM, a New Online Tool to Help People with Multiple Sclerosis Attain Personal Goals investment picks
Biogen Idec Inc. (NASDAQ: BIIB) today reported third quarter 2014 results, including revenue of $2.5 billion, a 37% increase compared to the third quarter of 2013.
Sign-up for Biogen Idec Third Quarter 2014 Revenues Increase 37% to $2.5 Billion investment picks
Biogen Idec (NASDAQ: BIIB) today announced that two leading neuroscientists have joined the company to advance its research in neurodegenerative diseases.
Sign-up for Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases investment picks
Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) of ELOCTA ™ (rFVIIIFc), a recombinant factor VIII Fc fusion protein product candidate for the treatment of hemophilia A.
Sign-up for Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review investment picks
Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will present at the 2014 Deutsche Bank BioFEST Conference.
Sign-up for Biogen Idec to Present at the 2014 Deutsche Bank BioFEST Conference investment picks
COPENHAGEN, Denmark, Nov.
Sign-up for Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany investment picks
Biogen Idec (NASDAQ: BIIB) will present data supporting its approved hemophilia therapies at the 56 th Annual Meeting of the American Society of Hematology (ASH) taking place in San Francisco, December 6-9.
Sign-up for Biogen Idec to Present Data from Hematology Programs, Including ELOCTATE™ and ALPROLIX® at ASH Annual Meeting investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
ETFS Holding Biogen Idec Inc
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Bill Barrett Corporation  |  Next: ETFS Holding Biomarin Pharmaceutical, Inc.